ASB16 and cancer: In the comparison of different stages, ASB16-AS1 was differentially expressed in 8 cancer types [(ACC, I vs IV, p =0.008; II vs IV, p =0.001); (ESCA, I vs II, p =0.011; I vs III, p =0.046); (kidney chromophobe, KICH, I vs II, p =0.033); (KIRC, I vs IV, p =0.019); (LIHC, I vs III, p =0.016); (LUAD, I vs II, p =0.044; I vs III, p =0.020); (PAAD, I vs II, p =0.009); (STAD, III vs IV, p =0.016)].